1Vogl TJ,Trapp M,Schroeder H,et al.Transarterial chemoembolization for hepatcocellular carcinoma:volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.Radiology,2000,214(2):349 ～ 357. 被引量：1
10Ishii H,Okada S,Sato T,et al.Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization [J].Hepatogastroenterology,1996,43:644-650. 被引量：1
5Georgiades C,Geschwind JF,Harrison N,et al. Lack of re- sponse after initial chemoembolization for hepatocellular carci- noma:does it predict failure of subsequent treatment. Radiolo- gy,2012,265( 1):115-123. 被引量：1
6Luo J,Guo RP,Lai EC,et al. Transarterial chernoembolization for unreseetable hepatocellular carcinoma with portal vein tu- mor thrombosis:a prospective comparative study. Ann Surg On- col,2011,18(2):413-420. 被引量：1
7Prajapati HJ,Xing M,Spivey JR,et al. Survival,efficacy,and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC. A JR,2014,203(6):W706-W714. 被引量：1
9Lee DH,Lee JM,Lee JY,et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment:long-term re- sults and prognostic factors in 162 patients with cirrhosis. Ra- diology, 2014,270(3 ):900-909. 被引量：1
10Huang G, Chen X,Lau WY, et al. Quality of life after surgical resection compared with radiofrequency ablation for small hep- atocellular carcinomas.Br J Surg,2014,101(8):1006-1015. 被引量：1
